Tag Archives: health

MassBio Releases Statement Following Cost Trends Hearings


MassBio issues this statement, following the Massachusetts’ Health Policy Commission’s (HPC) hearing earlier this week on the cost and value of health care cost trends. BIO stands with MassBio in our commitment to addressing the true cost and value of innovative medical therapies and their place within cost containment efforts across the entire healthcare system today. Innovation in biopharmaceuticals saves lives. It also saves money. Every reduced hospital stay, every surgery avoided, every inoculation can help reduce Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Benefiting from Innovative Clinical Trial Designs


Clinical trial success rates have been known to be low for some time now, but that does not imply they will remain low forever. As more tools become available to clinical trial sponsors, technical operators and even patients, future clinical success may look nothing like it has over the last decade. Taking steps to change old fashioned protocols were panelist that gathered for today’s panel on clinical trial innovation trends at the BIO Investor Forum Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Investor Forum Session on Advancing Immuno–Oncology

At the 2016 BIO Investor Forum, the first session held was titled “The Intersection of Inflammation and Immuno-Oncology: Risks and Opportunities.” Moderated by Michael King, Managing Director and Senior Research Analyst at JMP Securities, panelist included: Jay Venkatesan, MD, President & Director, Alpine Immune Sciences Pablo Cagnoni, MD, President & Chief Executive Officer, Tizona Therapeutics Alex Szidon, PhD, Executive Director, Business Development & Licensing; Head of West Coast Innovation Hub, Merck & Co. Inc. Paul Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Lawsuit Against UnitedHealth Put Insurers’ Practices Under Scrutiny


Reuters reports that UnitedHealth Group, the nation’s largest insurer, has been sued by three patients who’ve accused the massive insurance conglomerate of significantly over-charging them for co-pays for prescription drugs. The report alleges the co-pays were far in excess of the actual cost of the drug and the insurer kept the difference. According to Reuters: “For example, the lawsuit claims, one class member paid a $50 co-payment for Sprintec, a contraceptive, while UnitedHealth paid the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Cancer Docs Weigh in on Medicare Part B Demo


This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford Hudis, MD shared their thoughts in The Hill on how “We can do better than Medicare Part B demo.” At the forefront of oncology, they remind us that we are living in remarkable times of real progress – treatment options are ever-improving as is the number of cancer survivors. However, the experimental nature of Medicare Part B demo poses a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,